- Fertilité Après Traitement Anti-Cancéreux
- Préserver la Fertilité: Pour Qi?
- Published:
Cryoconservation du tissue testiculaire chez l’enfant: comment préserver la fertilité chez le jeune garçon?
Cryopreservation of testicular tissue in boys: how can the boy’s fertility be preserved?
Andrologie volume 14, pages 404–411 (2004)
Resume
La prise en charge thérapeutique des cancers de l’enfant s’est considérablement améliorée depuis les trente dernières années avec un taux de survie à long terme atteignant les 70%. Cependant, l’amélioration de l’efficacité thérapeutique s’associe à une augmentation des effets indésirables. Parmi les effets morbides, la toxicité sur le tissue gonadique est la plus fréquemment rencontrée et peut entraîner une stérilité définitive à l’âge adulte.
La préservation de la fertilité de l’enfant doit être envisagée avant le début des traitements. Ainsi, chez la petite fille, la congélation et conservation du tissu ovarien s’est mise en place en France depuis quelques années. Chez le jeune garçon pubère, il est possible de proposer une autoconservation de spermatozoïdes obtenus dans un recueil après masturbation.
Cependant, chez le garçon pré pubère ou en cas d’échec au recueil de sperme, une autre stratégie de prise en charge doit être envisagée, elle implique en premier lieu le prélèvement chirurgical du tissue testiculaire avec deux options possible: i) la congélation du tissue testiculaire entier ou ii) la congélation de cellules germinales immatures et/ou de cellules germinales matures (spermatozoïdes).
L’utilisation ultérieure du tissue testiculaire immature cryoconservé pourra s’effectuer soit après maturationin vitro des cellules germinales (spermatogenèsein vitro), soit par transplantation des cellules germinales par greffe autologue voire xénogreffe. Le risque de la greffe autologue est la réintroduction de l’affection maligne chez le patient, alors que la xénogreffe élimine ce risque. Cependant, cette dernière approche soulève d’autres interrogations à la fois d’ordre éthique et biologique.
Abstract
Survival rates for almost all types of childhood cancer have improved over the last 30 years. Estimates suggest that, in 2010, 1 out of 715 adolescents and young adults will be a long-term survivor of childhood cancer. With current therapy, 70% of children are cured. The increased number of survivors has focused attention on the many long-term or late sequelae of treatment. Most of the effects cannot be detected at the end of therapy, but only become apparent with puberty, growth and the normal aging process. Among the various sequelae, gonadal dysfunction is observed and the degree of gonadal damage depends on the type and total doses of chemotherapy and/or radiotherapy. The male gonald is also more sensitive to cancer therapy than the female gonad.
Cryopreservation of ejaculated spermatozoa should be proposed for sexually mature boys. However, when ejaculated semen samples cannot be collected, or in the case of prepubertal boys who are not yet able to produce spermatozoa, another strategy must be used: testicular biopsy associated with cryopreservation of (i) testicular tissue, or (ii) isolated testicular spermatozoa or (iii) immature germ cells. The future use of immature testicular tissue will depend on the development of novel technologies in humans such as germ cellin vitro maturation, or autologous or xenogeneic germ cell transplantation.
References
BAHADUR G., CHATTERJEE R., RALPH D.: Testicular tissue cryopreservation in boys. Ethical and legal issues: case report. Hum. Reprod., 2000, 15: 1416–1420.
BAHADUR G., LING K.L., HART R. et al.: Semen production in adolescent cancer patients. Hum. Reprod., 2002, 17: 2654–2656.
BAHADUR G., LING K.L., HART R. et al.: Semen quality and cryopreservation in adolescent cancer patients. Hum. Reprod., 2002, 17: 3157–3161.
BIRCH J.M., MARSDEN H.B., JONES P.H., PEARSON D., BLAIR V.: Improvements in survival from childhood cancer: results of a population based survey over 30 years. Br. Med. J. (Clin. Res. Ed.), 1988, 296: 1372–1376.
BIRCH J.M., ALSTON R.D., QUINN M., KELSEY A.M.: Incidence of malignant disease by morphological type, in young persons aged 12–24 years in England, 1979–1997. Eur. J. Cancer, 2003, 39: 2622–2631.
BIRCH J.M., ALSTON R.D., KELSEY A.M. et al.: Classification and incidence of cancers in adolescents and young adults in England 1979–1997. Br. J. Cancer, 2002, 87: 1267–1274.
BRINSTER R.L., ZIMMERMANN J.W.: Spermatogenesis following male germ-cell transplantation. Proc. Natl. Acad. Sci. (USA), 1994, 91: 11298–11302.
BROOK P.F., RADFORD J.A., SHALET S.M., JOYCE A.D., GOSDEN R.G.: Isolation of germ cells from human testicular tissue for low temperature storage and autotransplantation. Fertil. Steril., 2001, 75: 269–274.
BROUGHAM M.F., KELNAR C.J., SHARPE R.M., WALLACE W.H.: Male fertility following childhood cancer: current concepts and future therapies. Asian J. Androl., 2003, 5: 325–337.
CENTOLA G.M., KELLER J.W., HENZLER M., RUBIN P.: Effect of low-dose testicular irradiation on sperm count and fertility in patients with testicular seminoma. J. Androl., 1994, 15: 608–613.
CLIFTON D.K., BREMNER W.J.: The effect of testicular x-irradiation on spermatogenesis in man. A comparison with the mouse. J. Androl., 1983, 4: 387–392.
CLOUTHIER D.E., AVARBOCK M.R., MAIKA S.D., HAMMER R.E., BRINSTER R.L.: Rat spermatogenesis in mouse testis. Nature, 1996, 381: 418–421.
CREMADES N., BERNABEU R., BARROS A., SOUSA M.:In vitro maturation of round spermatids using co-culture on Vero cells. Hum. Reprod., 1999, 14: 1287–1293.
DE ROOIJ D.G., GROOTEGOED J.A.: Spermatogonial stem cells. Curr. Opin. Cell Biol., 1998, 10: 694–701.
FENG L.X., CHEN Y., DETTIN L. et al.: Generation andin vitro differentiation of a spermatogonial cell line. Science, 2002, 297: 392–395.
FISHEL S., ASLAM I., TESARIK J.: Spermatid conception: a stage too early, or a time too soon? Hum. Reprod., 1996, 11: 1371–1375.
FREDERICKX V., MICHIELS A., GOOSSENS E. et al.: Recovery, survival and functional evaluation by transplantation of frozen-thawed mouse germ cells. Hum. Reprod., 2004, 19: 948–953.
GIUILI G., TOMLJENOVIC A., LABRECQUE N. et al.: Murine spermatogonial stem cells: targeted transgene expression and purification in an active state. EMBO Rep., 2002, 3: 753–759.
GRUNDY R., GOSDEN R.G., HEWITT M. et al.: Fertility preservation for children treated for cancer (1): scientific advances and research dilemmas. Arch. Dis. Child., 2001, 84: 355–359.
HOVATTA O., SILYE R., KRAUSZ T. et al.: Cryopreservation of human ovarian tissue using dimethylsulphoxide and propanediol-sucrose as cryoprotectants. Hum. Reprod., 1996, 11: 1268–1272.
HOVATTA O.: Cryopreservation of testicular tissue in young cancer patients. Hum. Reprod. Update, 2001, 7: 378–383.
HUE D., STAUB C., PERRARD-SAPORI M.H. et al.: Meiotic differentiation of germinal cells in three-week cultures of whole cell population from rat seminiferous tubules. Biol. Reprod., 1998, 59: 379–387.
IZADYAR F., MATTHIJS-RIJSENBILT J.J., DEN OUDEN K. et al.: Development of a cryopreservation protocol for type A spermatogonia. J. Androl., 2002, 23: 537–545.
JAHNUKAINEN K., HOU M., PETERSEN C. et al.: Intratesticular transplantation of testicular cells from leukemic rats causes transmission of leukemia. Cancer. Res. 2001, 61(2): 706–710.
KANATSU-SHINOHARA M., OGONUKI N., INOUE K. et al.: Restoration of fertility in infertile mice by transplantation of cryopreserved male germline stem cells. Hum. Reprod., 2003, 18: 2660–2667.
LACHAM-KAPLAN O.: In vivo and in vitro differentiation of male germ cells in the mouse. Reproduction, 2004, 128: 147–152.
LITTLEY M.D., SHALET S.M., BEARDWELL C.G., ROBINSON E.L., SUTTON M.L.: Radiation-induced hypopituitarism is dose-dependent. Clin. Endocrinol. (Oxf), 1989, 31: 363–373.
MCLEAN D.J., RUSSELL L.D., GRISWOLD M.D.: Biological activity and enrichment of spermatogonial stem cells in vitamin A-deficient and hyperthermia-exposed testes from mice based on colonization following germ cell transplantation. Biol. Reprod., 2002, 66: 1374–1379.
MEACHEM S., VON SCHONFELDT V., SCHLATT S.: Spermatogonia: stem cells with a great perspective. Reproduction, 2001, 121: 825–834.
MEISTRICH M.L., WILSON G., KANGASNIEMI M., HUHTANIEMI I.: Mechanism of protection of rat spermatogenesis by hormonal pretreatment: stimulation of spermatogonial differentiation after irradiation. J. Androl., 2000, 21: 464–469.
MEISTRICH M.L., SHETTY G.: Suppression of testosterone stimulates recovery of spermatogenesis after cancer treatment. Int. J. Androl., 2003, 26: 141–146.
MERTENS A.C., YASUI Y., NEGLIA J.P. et al.: Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J. Clin. Oncol., 2001, 19: 3163–3172.
MULLER J., SKAKKEBAEK N.E.: Quantification of germ cells and seminiferous tubules by stereological examination of testicles from 50 boys who suffered from sudden death. Int. J. Androl., 1983, 6: 143–156.
MULLER J., SONKSEN J., SOMMER P. et al.: Cryopreservation of semen from pubertal boys with cancer. Med. Pediatr. Oncol., 2000, 34: 191–194.
NAGANO M., AVARBOCK M.R., LEONIDA E.B., BRINSTER C.J., BRINSTER R.L.: Culture of mouse spermatogonial stem cells. Tissue Cell, 1998, 30: 389–397.
NAGANO M., MCCARREY J.R., BRINSTER R.L.: Primate spermatogonial stem cells colonize mouse testes. Biol. Reprod., 2001, 64: 1409–1416.
NAGANO M., PATRIZIO P., BRINSTER R.L.: Long-term survival of human spermatogonial stem cells in mouse testes. Fertil. Steril., 2002, 78: 1225–1233.
NISTAL M., PANIAGUA R.: Occurrence of primary spermatocytes in the infant and child testis. Andrologia, 1984, 16: 532–536.
OEFFINGER K.C., HUDSON M.M.: Long-term complications following childhood and adolescent cancer: foundations for providing risk-based health care for survivors. CA Cancer J. Clin., 2004, 54: 208–236.
OGAWA T., DOBRINSKI I., AVARBOCK M.R., BRINSTER R.L.: Xenogeneic spermatogenesis following transplantation of hamster germ cells to mouse testes. Biol. Reprod., 1999, 60: 515–521.
PARKS J.E., LEE D.R., HUANG S., KAPROTH M.T.: Prospects for spermatogenesis in vitro. Theriogenology, 2003, 59: 73–86.
POSTOVSKY S., LIGHTMAN A., AMINPOUR D. et al.: Sperm cryopreservation in adolescents with newly diagnosed cancer. Med. Pediatr. Oncol., 2003, 40: 355–359.
REMONTET L., ESTEVE J., BOUVIER A.M. et al.: Cancer incidence and mortality in France over the period 1978–2000. Rev. Épidemiol. Santé Publique, 2003, 51: 3–30.
RIVES N.: Comment identifier le spermatozoide vivant? Andrologie, 2002, 12: 332–341.
SANDERS J.E., HAWLEY J., LEVY W. et al.: Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood, 1996, 87: 3045–3052.
SCHLATT S., ROSIEPEN G., WEINBAUER G.F. et al.: Germ cell transfer into rat, bovine, monkey and human testes. Hum. Reprod., 1999, 14: 144–150.
SCHLATT S.: Spermatogonial stem cell preservation and transplantation. Mol. Cell. Endocrinol., 2002, 187: 107–111.
SCHLATT S.: Germ cell transplantation. Mol. Cell. Endocrinol., 2002, 186: 163–167.
SCHMIEGELOW M.L., SOMMER P., CARLSEN E. et al.: Penile vibratory stimulation and electroejaculation before anticancer therapy in two pubertal boys. J. Pediatr. Hematol. Oncol., 1998, 20: 429–430.
SHALET S.M., TSATSOULIS A., WHITEHEAD E., READ G.: Vulnerability of the human Leydig cell to radiation damage is dependent upon age. J. Endocrinol., 1989, 120: 161–165.
SHINOHARA T., AVARBOCK M.R., BRINSTER R.L.: Beta1-and alpha6-integrin are surface markers on mouse spermatogonial stem cells. Proc. Natl. Acad. Sci. (USA), 1999, 96: 5504–5509.
SHINOHARA T., INOUE K., OGONUKI N. et al.: Birth of offspring following transplantation of cryopreserved immature testicular pieces andin vitro microinsemination. Hum. Reprod., 2002, 17: 3039–3045.
SOFIKITIS N., MANTZAVINOS T., LOUTRADIS D. et al.: Ooplasmic injections of secondary spermatocytes for non-obstructive azoospermia. Lancet, 1998, 351: 1177–1178.
SOMMELET D., LACOUR B., CLAVEL J.: Epidémiologie des cancers de l’enfant. Bull. Acad. Natl. Med., 2003, 187: 711–737.
SPEISER B., RUBIN P., CASARETT G.: Aspermia following lower truncal irradiation in Hodgkin’s disease. Cancer, 1973, 32: 692–698.
SPRADLING A., DRUMMOND-BARBOSA D., KAI T.: Stem cells find their niche. Nature, 2001, 414: 98–104.
STAUB C., HUE D., NICOLLE J.C. et al.: The whole meiotic process can occur in vitro in untransformed rat spermatogenic cells. Exp. Cell. Res., 2000, 260: 85–95.
TESARIK J.: Fertilization of oocytes by injecting spermatozoa, spermatids and spermatocytes. Rev. Reprod., 1996, 1: 149–152.
TESARIK J., GUIDO M., MENDOZA C., GRECO E.: Human spermatogenesis in vitro: respective effects of follicle-stimulating hormone and testosterone on meiosis, spermiogenesis, and Sertoli cell apoptosis. J. Clin. Endocrinol. Metab., 1998, 83: 4467–4473.
TESARIK J., MENDOZA C., GRECO E.:In vitro maturation of immature human male germ cells. Mol. Cell. Endocrinol., 2000, 166: 45–50.
THOMSON A.B., CRITCHLEY H.O., WALLACE W.H.: Fertility and progeny. Eur. J. Cancer, 2002, 38: 1634–1644.
VAN DER WEE K.S., JOHNSON E.W., DIRAMI G., DYM T.M., HOFMANN M.C.: Immunomagnetic isolation and long-term culture of mouse type A spermatogonia. J. Androl., 2001, 22: 696–704.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communication au Colloque de la Fédération des CECOS, Lyon, 18 mars 2004.
Préserver la fertilité des patients soumis à des traitements anticancéreux: la cryopréservation des gamètes et du tissu gonadique.
Rights and permissions
About this article
Cite this article
Rives, N., Macé, B. Cryoconservation du tissue testiculaire chez l’enfant: comment préserver la fertilité chez le jeune garçon?. Androl. 14, 404–411 (2004). https://doi.org/10.1007/BF03035172
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03035172